Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Selectis Health (GBCS) Enterprise Value (2017 - 2025)

Selectis Health's Enterprise Value history spans 14 years, with the latest figure at -$1.0 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$1.0 million for Q4 2025, down 48.7% from a year ago — trailing twelve months through Dec 2025 was -$1.0 million (down 48.7% YoY), and the annual figure for FY2025 was -$1.0 million, down 48.7%.
  • Enterprise Value for Q4 2025 was -$1.0 million at Selectis Health, down from -$417125.0 in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$417125.0 in Q3 2025 to a low of -$3.1 million in Q3 2023.
  • The 5-year median for Enterprise Value is -$851367.0 (2021), against an average of -$1.0 million.
  • The sharpest move saw Enterprise Value skyrocketed 81.36% in 2021, then tumbled 258.77% in 2023.
  • Year by year, Enterprise Value stood at -$878043.0 in 2021, then tumbled by 175.23% to -$2.4 million in 2022, then skyrocketed by 38.57% to -$1.5 million in 2023, then soared by 54.17% to -$680332.0 in 2024, then crashed by 48.7% to -$1.0 million in 2025.
  • According to Business Quant data, Enterprise Value over the past three periods came in at -$1.0 million, -$417125.0, and -$559983.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.